Scott M. Giacobello

WHWK

CHIEF FINANCIAL OFFICER · WHITEHAWK THERAPEUTICS, INC. · CIK 0001754154

FILING MIX · LIFETIME55%/45%

BUYS

SELLS

TOTAL VALUE

$1.04M

COMPANIES

ACTIVE SINCE

Apr 2025

HOLDINGS NOW

333,489

AVG SELL PX

$4.03

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

3 backtested trades · 8 horizons · 9 pendingHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Scott M. Giacobello, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	3	+33.33%	+10.99%	+0.47%	+10.52%	+6.85%	—
14d	3	+33.33%	+6.25%	+0.52%	+5.73%	+1.93%	—
30d	3	+0.00%	+19.40%	+2.44%	+16.96%	+13.80%	—
60d	3	+33.33%	+7.83%	+5.56%	+2.27%	-1.74%	—
90d	3	+33.33%	+12.52%	+7.09%	-11.16%	-11.16%	—
180d	3(3 pending)	—	—	—	—	—	—
1y	3(3 pending)	—	—	—	—	—	—
2y	3(3 pending)	—	—	—	—	—	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

WHWK · 333,489 shares · as of May 14, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2025

2026

FLOW · 6 buys / 5 sellsCOVERAGE · 5 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
WHWK WHITEHAWK THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	38,265	$3.92	$150.0K	333,489	May 14, 2026	May 18, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	SALE CHIEF FINANCIAL OFFICER	141,600	$4.13	$584.8K	295,224	Apr 16, 2026	Apr 17, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	SALE CHIEF FINANCIAL OFFICER	77,000	$3.86	$297.2K	436,824	Apr 15, 2026	Apr 17, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	PURCHASE CHIEF FINANCIAL OFFICER	473,902	—	—	502,002	Apr 1, 2026	Apr 3, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	SALE CHIEF FINANCIAL OFFICER	473,902	—	—	0	Apr 1, 2026	Apr 3, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	300,677	—	—	300,677	Apr 1, 2026	Apr 3, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	SALE CHIEF FINANCIAL OFFICER	2,594	$3.31	$8.6K	28,100	Mar 2, 2026	Mar 10, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	PURCHASE CHIEF FINANCIAL OFFICER	6,750	—	—	30,694	Mar 1, 2026	Mar 10, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	SALE CHIEF FINANCIAL OFFICER	6,750	—	—	13,500	Mar 1, 2026	Mar 10, 2026 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	473,902	—	—	473,902	Apr 1, 2025	Apr 3, 2025 ↗	View →
WHWK WHITEHAWK THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	473,902	—	—	473,902	Apr 1, 2025	Apr 3, 2025 ↗	View →

Other insiders · WHWK

Loading peer insiders…

About this filer

CIK 0001754154

ROLE

CHIEF FINANCIAL OFFICER

PRIMARY

WHWK

COMPANIES

ACTIVE SINCE

Apr 2025

MARKETPEEL · /INSIDER/0001754154DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Scott M. Giacobello

The morning brief, before the bell.